NEW Dividiend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

Waters Corporation WAT | NYSE

$371.20 $0.00 | 0.00%

Next Earnings: Jul 28, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
52-Week Range: $275.05 - $414.15

10 Year WAT Performance Metrics:

Total Return (with DRIP): 136.3% (8.98% CAGR)
Total Return (no DRIP): 136.3% (8.98% CAGR)
Share Price: 136.3% (8.98% CAGR)
Dividend Increase: 0.0% (0.00% CAGR)
Dividend Yield (FWD): 0.04% ($0.16)
WAT 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

WAT Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
WAT Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Share Price
WAT Price CAGR:1Y: 22.77%2Y: 8.05%5Y: -0.39%10Y: 8.96%

Unlock All Reports & Research Dividend Stocks.

[lev_ptables no_sale]

WAT Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - WAT
7-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - WAT
7-Day FREE Trial Get Full Access Now!

WAT Earnings, Revenue, Cash & Debt, Shares Outstaning:

WAT - Revenue
7-Day FREE Trial Get Full Access Now!
WAT Revenue CAGR:1Y: 91.48%2Y: 41.05%5Y: 15.80%10Y: 10.30%
WAT - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
WAT EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Net Income
7-Day FREE Trial Get Full Access Now!
WAT Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - EBITDA
7-Day FREE Trial Get Full Access Now!
WAT EBITDA CAGR:1Y: -48.67%2Y: -25.81%5Y: -12.94%10Y: -0.84%
WAT - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
WAT Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
WAT Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Operating Income
7-Day FREE Trial Get Full Access Now!
WAT Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Gross Profit
7-Day FREE Trial Get Full Access Now!
WAT Gross Profit CAGR:1Y: 54.56%2Y: 28.03%5Y: 10.92%10Y: 8.06%
WAT - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
WAT Shares Outstanding CAGR:1Y: 37.56%2Y: 17.56%5Y: 5.57%10Y: 0.02%
WAT - Share Buybacks
7-Day FREE Trial Get Full Access Now!
WAT Share Buybacks CAGR:1Y: -13.88%2Y: -4.25%5Y: -41.38%10Y: -18.73%
WAT - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
WAT Stock-Based Comp CAGR:1Y: 55.30%2Y: 35.38%5Y: 19.22%10Y: 2.36%
WAT - Expenses
7-Day FREE Trial Get Full Access Now!
WAT Expenses CAGR:1Y: 51.50%2Y: 16.66%5Y: -0.26%10Y: 4.69%
WAT - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
WAT - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
WAT - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
WAT - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
WAT - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
WAT - Cash & Debt
7-Day FREE Trial Get Full Access Now!
WAT - Dividends
7-Day FREE Trial Get Full Access Now!
WAT Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
WAT - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
WAT Revenue CAGR:1Y: 91.48%2Y: 41.05%5Y: 15.80%10Y: 10.30%
WAT - Revenue by Region
7-Day FREE Trial Get Full Access Now!
WAT Revenue CAGR:1Y: 91.48%2Y: 41.05%5Y: 15.80%10Y: 10.30%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

WAT - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
WAT Actual Revenue CAGR:1Y: 91.48%2Y: 41.05%5Y: 15.80%10Y: 10.30%
WAT - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
WAT Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
WAT Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
WAT Actual EBITDA CAGR:1Y: -48.67%2Y: -25.81%5Y: -12.94%10Y: -0.84%

Ratios, Profit Margins & Return on Capital:

WAT - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
WAT Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
WAT - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
WAT Gross Profit Margin CAGR:1Y: -19.28%2Y: -9.23%5Y: -4.21%10Y: -2.03%
WAT - Price to Earnings
7-Day FREE Trial Get Full Access Now!
WAT - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
WAT - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
WAT - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

WAT Dividends Info:

Annual Dividend: $0.16
Forward Yield: 0.04%
Ex-Dividend Date: 1996-11-26
Lifetime Dividends / Share: $0.04

WAT Dividend History: Dates, Payments & Yield list

Below is a schedule of all WAT dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
11/26/199611/28/1996$0.0400.59%2.36%$6.78

Projected Future Returns & Dividends for WAT

Based on past 10-year performance, here are WAT growth metrics:

Share price CAGR of +8.96%
Dividend CAGR of +0%

Using WAT CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

WAT (DRIP)WAT - No DRIP
Current Price$371.20$371.20
Start Shares26.9426.94
Start Value$10,000$10,000
  
After 10 years:
Final Share Count27.0226.94
Dividends Payment$0.04$0.04
Annual Dividends$4$4
Yield on cost0.04%0.04%
Share Price$875.41$875.41
Total Dividends$43$43
Final Value$23,655$23,626

Estimated Future Value + Dividends - WAT

NOTE: Above numbers are our estimate based on WAT's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

[lev_ptables no_sale]

Company Info

Waters Corporation (WAT) had its IPO on 1995-11-17, and is trader on NYSE stock exchange.

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

WAT website: https://www.waters.com


Get Full Access to All Reports with DRIPCalc PRO

[lev_ptables no_sale]